FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282947051> ?p ?o ?g. }

• W4282947051 endingPage "200" @default.
• W4282947051 startingPage "191" @default.
• W4282947051 abstract "Background: Black adults have a higher incidence of peripheral artery disease and limb amputations than White adults in the United States. Given that peripheral endovascular intervention (PVI) is now the primary revascularization strategy for peripheral artery disease, it is important to understand whether racial differences exist in PVI incidence and outcomes. Methods: Data from fee-for-service Medicare beneficiaries ≥66 years of age from 2016 to 2018 were evaluated to determine age- and sex-standardized population-level incidences of femoropopliteal PVI among Black and White adults over the 3-year study period. Patients’ first inpatient or outpatient PVIs were identified through claims codes. Age- and sex-standardized risks of the composite outcome of death and major amputation within 1 year of PVI were examined by race. Results: Black adults underwent 928 PVIs per 100 000 Black beneficiaries compared with 530 PVIs per 100 000 White beneficiaries (risk ratio, 1.75 [95% CI, 1.73–1.77]; P <0.01). Black adults who underwent PVI were younger (mean age, 74.5 years versus 76.4 years; P <0.01), were more likely to be female (52.8% versus 42.7%; P< 0.01), and had a higher burden of diabetes (70.6% versus 56.0%; P <0.01), chronic kidney disease (67.5% versus 56.6%; P< 0.01), and heart failure (47.4% versus 41.7%; P< 0.01) than White adults. When analyzed by indication for revascularization, Black adults were more likely to undergo PVI for chronic limb-threatening ischemia than White adults (13 023 per 21 352 [61.0%] versus 59 956 per 120 049 [49.9%]; P< 0.01). There was a strong association between Black race and the composite outcome at 1 year (odds ratio, 1.21 [95% CI, 1.16–1.25]). This association persisted after adjustment for socioeconomic status (odds ratio, 1.08 [95% CI, 1.03–1.13]) but was eliminated after adjustment for comorbidities (odds ratio, 0.96 [95% CI, 0.92–1.01]). Conclusions: Among fee-for-service Medicare beneficiaries, Black adults had substantially higher population-level PVI incidence and were significantly more likely to experience adverse events after PVI than White adults. The association between Black race and adverse outcomes appears to be driven by a higher burden of comorbidities. This analysis emphasizes the critical need for early identification and aggressive management of peripheral artery disease risk factors and comorbidities to reduce Black–White disparities in the development and progression of peripheral artery disease and the risk of adverse events after PVI." @default.
• W4282947051 created "2022-06-16" @default.
• W4282947051 creator A5000203028 @default.
• W4282947051 creator A5013627666 @default.
• W4282947051 creator A5019226827 @default.
• W4282947051 creator A5020954018 @default.
• W4282947051 creator A5021069598 @default.
• W4282947051 creator A5037267938 @default.
• W4282947051 creator A5046721150 @default.
• W4282947051 creator A5054703789 @default.
• W4282947051 creator A5065985671 @default.
• W4282947051 creator A5089120659 @default.
• W4282947051 date "2022-07-19" @default.
• W4282947051 modified "2023-10-01" @default.
• W4282947051 title "Differences in Comorbidities Explain Black–White Disparities in Outcomes After Femoropopliteal Endovascular Intervention" @default.
• W4282947051 cites W1834701545 @default.
• W4282947051 cites W1999790968 @default.
• W4282947051 cites W2016148190 @default.
• W4282947051 cites W2016596948 @default.
• W4282947051 cites W2022911635 @default.
• W4282947051 cites W2028382800 @default.
• W4282947051 cites W2057151903 @default.
• W4282947051 cites W2095219849 @default.
• W4282947051 cites W2101872043 @default.
• W4282947051 cites W2121275621 @default.
• W4282947051 cites W2122523807 @default.
• W4282947051 cites W2148374679 @default.
• W4282947051 cites W2193709722 @default.
• W4282947051 cites W2200657718 @default.
• W4282947051 cites W2530935316 @default.
• W4282947051 cites W2554148734 @default.
• W4282947051 cites W2562897042 @default.
• W4282947051 cites W2596179513 @default.
• W4282947051 cites W2611241853 @default.
• W4282947051 cites W2783484560 @default.
• W4282947051 cites W2789737428 @default.
• W4282947051 cites W2896986290 @default.
• W4282947051 cites W2986214232 @default.
• W4282947051 cites W3012000716 @default.
• W4282947051 cites W3016065877 @default.
• W4282947051 cites W3102378350 @default.
• W4282947051 cites W3136295653 @default.
• W4282947051 cites W4210242902 @default.
• W4282947051 cites W4226184263 @default.
• W4282947051 doi "https://doi.org/10.1161/circulationaha.122.058998" @default.
• W4282947051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35695005" @default.
• W4282947051 hasPublicationYear "2022" @default.
• W4282947051 type Work @default.
• W4282947051 citedByCount "8" @default.
• W4282947051 countsByYear W42829470512022 @default.
• W4282947051 countsByYear W42829470512023 @default.
• W4282947051 crossrefType "journal-article" @default.
• W4282947051 hasAuthorship W4282947051A5000203028 @default.
• W4282947051 hasAuthorship W4282947051A5013627666 @default.
• W4282947051 hasAuthorship W4282947051A5019226827 @default.
• W4282947051 hasAuthorship W4282947051A5020954018 @default.
• W4282947051 hasAuthorship W4282947051A5021069598 @default.
• W4282947051 hasAuthorship W4282947051A5037267938 @default.
• W4282947051 hasAuthorship W4282947051A5046721150 @default.
• W4282947051 hasAuthorship W4282947051A5054703789 @default.
• W4282947051 hasAuthorship W4282947051A5065985671 @default.
• W4282947051 hasAuthorship W4282947051A5089120659 @default.
• W4282947051 hasBestOaLocation W42829470511 @default.
• W4282947051 hasConcept C120665830 @default.
• W4282947051 hasConcept C121332964 @default.
• W4282947051 hasConcept C126322002 @default.
• W4282947051 hasConcept C134018914 @default.
• W4282947051 hasConcept C141071460 @default.
• W4282947051 hasConcept C164705383 @default.
• W4282947051 hasConcept C2776204877 @default.
• W4282947051 hasConcept C2777466421 @default.
• W4282947051 hasConcept C2778213512 @default.
• W4282947051 hasConcept C2778653478 @default.
• W4282947051 hasConcept C2779464278 @default.
• W4282947051 hasConcept C2781099653 @default.
• W4282947051 hasConcept C2908647359 @default.
• W4282947051 hasConcept C3018348675 @default.
• W4282947051 hasConcept C500558357 @default.
• W4282947051 hasConcept C555293320 @default.
• W4282947051 hasConcept C61511704 @default.
• W4282947051 hasConcept C71924100 @default.
• W4282947051 hasConcept C99454951 @default.
• W4282947051 hasConceptScore W4282947051C120665830 @default.
• W4282947051 hasConceptScore W4282947051C121332964 @default.
• W4282947051 hasConceptScore W4282947051C126322002 @default.
• W4282947051 hasConceptScore W4282947051C134018914 @default.
• W4282947051 hasConceptScore W4282947051C141071460 @default.
• W4282947051 hasConceptScore W4282947051C164705383 @default.
• W4282947051 hasConceptScore W4282947051C2776204877 @default.
• W4282947051 hasConceptScore W4282947051C2777466421 @default.
• W4282947051 hasConceptScore W4282947051C2778213512 @default.
• W4282947051 hasConceptScore W4282947051C2778653478 @default.
• W4282947051 hasConceptScore W4282947051C2779464278 @default.
• W4282947051 hasConceptScore W4282947051C2781099653 @default.
• W4282947051 hasConceptScore W4282947051C2908647359 @default.
• W4282947051 hasConceptScore W4282947051C3018348675 @default.
• W4282947051 hasConceptScore W4282947051C500558357 @default.
• W4282947051 hasConceptScore W4282947051C555293320 @default.

• next